Radiation Oncology Research Center, Cancer Institute,Tehran University of Medical Sciences, Tehran, Iran E-mail: amoozfar@tums.ac.ir
Abstract
Cervical cancer is one of the most common gynecological cancers in Iranian women. This study was initiated to assess whether the combination of paclitaxel and cisplatin with radiation might feasible for these patients. The aim was to assess tumor response and toxicity of weekly cisplatin and paclitaxel along with radiotherapy in the treatment of cervical cancer. Women with primary untreated squamous cell carcinoma of the cervix with FIGO stages IB2 to IIIB were treated with weekly injections of cisplatin 30 mg/m2 and paclitaxel 35 mg/m2 for 5-6 weeks along with radiotherapy. A total of 25 patients were enrolled in this study who completed the intended treatment. Disease was assessed prior to treatment by pelvic examination and contrast enhanced MRI of the abdomen and pelvis. Response was assessed 1 month after completion of treatment by physical examination and 3 months after also by MRI.Toxicity was assessed and was graded using RTOG grading. There was a complete response rate of 84% after 3 months. The major toxicity was grade 1 and 2 anemia (92%). The mean duration of treatment was 58 days. In conclusion, combination chemotherapy with cisplatin and paclitaxel along with radiotherapy in patients with locally advanced squamous cell carcinoma of cervixwas well tolerated, in contrast to other studies, but it seems that there was no increase in tumor response and progression free survival with this treatment regimen.
Kalaghchi, B., Abdi, R., Amouzegar-Hashemi, F., Esmati, E., & Alikhasi, A. (2016). Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer. Asian Pacific Journal of Cancer Prevention, 17(S3), 287-291.
MLA
Bita Kalaghchi; Robab Abdi; Farnaz Amouzegar-Hashemi; Ebrahim Esmati; Afsaneh Alikhasi. "Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer". Asian Pacific Journal of Cancer Prevention, 17, S3, 2016, 287-291.
HARVARD
Kalaghchi, B., Abdi, R., Amouzegar-Hashemi, F., Esmati, E., Alikhasi, A. (2016). 'Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer', Asian Pacific Journal of Cancer Prevention, 17(S3), pp. 287-291.
VANCOUVER
Kalaghchi, B., Abdi, R., Amouzegar-Hashemi, F., Esmati, E., Alikhasi, A. Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer. Asian Pacific Journal of Cancer Prevention, 2016; 17(S3): 287-291.
)